Related Experiment Video
Updated: Feb 25, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
[Effect of multidrug resistant associated protein 4 overexpression on lipopolysaccharide-induced vascular endothelial
Wenfang Xia1, Huanming Zhang, Yanlei Zheng
1Department of Critical Care Medicine, People's Hospital of Wuhan University, Wuhan 430060, Hubei, China. Corresponding author: Xia Wenfang,
Objective:
To investigate the effect of multidrug resistance protein 4 (MRP4) overexpression on lipopolysaccharide (LPS)-induced vascular endothelial hyperpermeability of rat pulmonary micro-vascular endothelial cells (PMVECs) and its molecule mechanism.
Methods:
Three to six passages of PMVECs were cultured in vitro, and they were divided into three groups: the cells in LPS group were only challenged by LPS 10 μg/mL after being cultured in serum-free medium for 24 hours; the cells in Ad-shRNA and Ad-MRP4 groups were infected with the empty virus control or recombinant adenovirus expressing MRP4 for 2 hours, and then were cultured in serum-free medium for 24 hours followed by stimulation of LPS 10 μg/mL. Endothelial permeability was assayed by the Transwell chamber models at 2, 6, 12, and 24 hours after LPS stimulation. Intracellular cyclic adenosine monophosphate (cAMP) levels were detected by enzyme-linked immunosorbent assay (ELISA). The morphological characteristics and distribution of F-actin was determined by laser confocal fluorescence microscope. The protein expressions of MRP4, β-catenin, vascular endothelium-cadherin (VE-cad) and ZO-1 were measured by Western Blot.
Results:
(1) After LPS stimulation, endothelium permeability and intracellular cAMP levels in PMVECs were significantly increased, peaked at 12 hours, and then decreased after 24 hours. Compared with LPS group and Ad-shRNA group, PMVECs of Ad-MRP4 group were exhibited a significant increase in endothelial permeability [12-hour permeability (A value): 1.88±0.06 vs. 1.12±0.17, 1.10±0.18] and a significant decrease in intracellular cAMP level [12-hour cAMP (μg/L): 2.39±0.02 vs. 2.97±0.01, 3.00±0.02, all P < 0.05]. There was no significant difference in endothelium permeability and intracellular cAMP levels at all time points between the LPS group and the Ad-shRNA group (all P > 0.05). (2) Under laser confocal fluorescence microscope, after LPS stimulation, the stress fiber formation was induced in three groups. But there were pronounced irregular aggregation of fiber in PMVECs of Ad-MRP4 group. (3) Furthermore, compared with LPS group and Ad-shRNA group, protein expression of MRP4 in Ad-MRP4 group was dramatically increased (gray value: 0.76±0.03 vs. 0.44±0.02, 0.43±0.02, both P < 0.05), and the protein expressions of β-catenin, VE-cad, and ZO-1 were significantly decreased [β-catenin (gray value): 0.14±0.03 vs. 0.23±0.04, 0.23±0.03); VE-cad (gray value): 0.21±0.01 vs. 0.34±0.02, 0.35±0.04; ZO-1 (gray value): 0.14±0.02 vs. 0.37±0.06, 0.33±0.07, all P < 0.05]. There was no significant difference in all protein expressions between the LPS group and Ad-shRNA group (all P > 0.05).
Conclusions:
MRP4 overexpression can decrease intracellular cAMP levels, reduce intercellular junction protein expression, and then exaggerate LPS-induced vascular endothelial hyperpermeability.
Insights
Multidrug resistance protein 4 (MRP4) overexpression worsens lipopolysaccharide (LPS)-induced hyperpermeability in pulmonary microvascular endothelial cells (PMVECs). This occurs by lowering cyclic adenosine monophosphate (cAMP) and reducing intercellular junction proteins.
Area of Science:
- Endothelial Biology
- Molecular Mechanisms of Disease
- Pharmacology
Background:
- Lipopolysaccharide (LPS) triggers vascular endothelial hyperpermeability, a key factor in inflammatory conditions.
- Multidrug resistance protein 4 (MRP4) is implicated in cellular transport and inflammatory responses.
Purpose of the Study:
- To investigate the impact of MRP4 overexpression on LPS-induced hyperpermeability in rat pulmonary micro-vascular endothelial cells (PMVECs).
- To elucidate the molecular mechanisms underlying MRP4's effect on endothelial barrier function.
Main Methods:
- PMVECs were cultured and divided into LPS, Ad-shRNA (control), and Ad-MRP4 (MRP4 overexpression) groups.
- Endothelial permeability, intracellular cyclic adenosine monophosphate (cAMP) levels, F-actin distribution, and protein expression (MRP4, β-catenin, VE-cad, ZO-1) were assessed.
- Transwell assays, ELISA, laser confocal microscopy, and Western blotting were employed.
Main Results:
- MRP4 overexpression significantly increased endothelial permeability and decreased intracellular cAMP levels in PMVECs stimulated with LPS.
- LPS challenge induced stress fiber formation, which was more pronounced and irregular in PMVECs overexpressing MRP4.
- MRP4 overexpression led to decreased expression of β-catenin, vascular endothelium-cadherin (VE-cad), and ZO-1.
Conclusions:
- MRP4 overexpression exacerbates LPS-induced vascular endothelial hyperpermeability.
- This effect is mediated by decreased intracellular cAMP levels and reduced expression of intercellular junction proteins.
- MRP4 represents a potential therapeutic target for conditions involving endothelial barrier dysfunction.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Formation of Lipopolysaccharides

